Kinetics of plasma-cell chimerism after allogeneic stem cell transplantation by highly sensitive real-time PCR based on sequence polymorphism and its value to quantify minimal residual disease in patients with multiple myeloma-Reference-Cited by-同舟云学术

Kinetics of plasma-cell chimerism after allogeneic stem cell transplantation by highly sensitive real-time PCR based on sequence polymorphism and its value to quantify minimal residual disease in patients with multiple myeloma

Published:2006-05 Issue:5 Volume:34 Page:688-694
ISSN:0301-472X
Container-title:Experimental Hematology
language:en
Short-container-title:Experimental Hematology

Author:

Kröger Nicolaus,Zagrivnaja Maria,Schwartz Sabine,Badbaran Anita,Zabelina Tatjana,Lioznov Michael,Ayuk Francis,Zander Axel,Fehse Boris

Publisher

Elsevier BV

Subject

Cancer Research,Cell Biology,Genetics,Hematology,Molecular Biology

Reference26 articles.

1. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT). Molecular remission after myeloablative allogeneic stem cell transplantation predicts a better relapse-free survival in patients with multiple myeloma;Corradini;Blood,2003

2. Molecular and clinical remissions in multiple myeloma: role of autologous and allogeneic transplantation of hematopoietic cells;Corradini;J Clin Oncol,1999

3. Molecular remission after allogeneic or autologous transplantation of hematopoietic stem cells for multiple myeloma;Martinelli;J Clin Oncol,2000

4. Allogeneic marrow transplantation for multiple myeloma: an analysis of risk factors on outcome;Bensinger;Blood,1996

5. The occurrence of graft-versus-host disease is the major predictive factor for response to donor lymphocyte infusions in multiple myeloma;Lokhorst;Blood,2004

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hematopoietic Stem Cell Transplantation for the Treatment of Autoimmune Neurological Diseases: An Update;Bioengineering;2023-01-29

2. Study of Immune Reconstitution after Allogeneic Hematopoietic Stem Cell Transplantation;Advances in Clinical Medicine;2023

3. Toward a Better Understanding of the Atypical Features of Chronic Graft-Versus-Host Disease: A Report from the 2020 National Institutes of Health Consensus Project Task Force;Transplantation and Cellular Therapy;2022-08

4. The significance of mixed chimaerism and cell lineage chimaerism monitoring in paediatric patients post haematopoietic stem cell transplant;British Journal of Haematology;2022-04-14

5. Strong Cellular Immune Response, but Not Humoral, against SARS-CoV-2 in Oncohematological Patients with Autologous Stem Cell Transplantation after Natural Infection;Journal of Clinical Medicine;2022-04-11